News & Perspective

Mar 01, 2011

Mar 01, 2011

HHS awards two contracts for recombinant flu vaccines

(CIDRAP News) – The US Department of Health and Human Services (HHS) yesterday announced that it has awarded $215 million in contracts to two companies to further the development of recombinant technology, a move designed to improve and speed production of pandemic and seasonal flu vaccines.

Jun 28, 2011

Jun 28, 2011

Federal review outlines new flu vaccine investments, challenges

(CIDRAP News) – The price-tag for federal investments in new flu vaccine technology has been difficult to get a handle on, but yesterday in a review for Congress the Government Accountability Office (GAO) put the number at $2.1 billion since fiscal year 2005.

Dec 13, 2011

Dec 13, 2011

Novartis says cell-based flu vaccine facility ready to produce

(CIDRAP News) – Novartis's new cell-culture based influenza vaccine factory in North Carolina has begun making a prepandemic H5N1 flu vaccine and is ready to start producing vaccines for a real pandemic when needed, the company and federal health officials announced yesterday.

The facility in Holly Springs, N.C., billed as the first of its kind in the United States, was dedicated yesterday after a long testing process.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»